Fidelity Health® vs Stock Analysis: Stocks & Funds
Revenue, downloads, ratings and category context for two iOS apps. Figures are estimates and should be read as ranges, not exact totals.
Fidelity Health®Fidelity Investments - Finance
Stock Analysis: Stocks & FundsVefir ehf. - Finance| Metric | Fidelity Health® | Stock Analysis: Stocks & Funds | Readout |
|---|---|---|---|
| Estimated revenue / mo | $*** - opens with trial | $*** - opens with trial | Partial signal |
| Revenue band | $*** - opens with trial | $*** - opens with trial | Use range + confidence |
| Estimated downloads / mo | $*** - opens with trial | $*** - opens with trial | Stock Analysis: Stocks & Funds |
| Download band | $*** - opens with trial | $*** - opens with trial | Use range + confidence |
| Rating | - | 4.89 | Stock Analysis: Stocks & Funds |
| Rating count | - | 5.5k | Stock Analysis: Stocks & Funds |
| Tracked keywords | — | 1 | Stock Analysis: Stocks & Funds |
| Category | Finance | Finance | Same market |
Which app is bigger?
Fidelity Health® and Stock Analysis: Stocks & Funds are compared inside Finance with monthly revenue, downloads, rating, review volume, keyword footprint, category placement and range context. Stock Analysis: Stocks & Funds leads on monthly downloads in the current readout, while a clean revenue readout is available only for Stock Analysis: Stocks & Funds in this pair. Stock Analysis: Stocks & Funds wins demand, Stock Analysis: Stocks & Funds has deeper review volume, and Stock Analysis: Stocks & Funds has the larger tracked keyword footprint. The better app depends on the job: choose the revenue leader when you need monetization proof, choose the download leader when reach matters, and choose the higher-rated or deeper-reviewed app when market trust is the constraint. Read both ranges rather than only the midpoint, then open the category hub and related collections to see whether this pair is an outlier or a normal category pattern.